Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients

NCT03832127 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: 18F-Fludarabine

Sponsor

Nantes University Hospital

Collaborators

[object Object]